510(k) Report

510(k) · Cleared

Cleared

Duracon Posterior Femoral Spacer

K963242510(k) TraditionalCleared Nov 14, 199687-day reviewClass II21 CFR 888.3560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Howmedica Corp. · JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer

Cleared on Nov 14, 1996 as substantially equivalent to K915512 (Pfizer Hospital Products Group, Inc., 1992) and 1 other predicate after an 87-day review. Its family tree reaches back 1 generation to 1991.

Decided
Nov 14, 1996
Review
87 days
Class
Class II
Product code
JWH
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K904208 (1991). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by generation 1 generation back: 1 other ancestor K904208 · Kinemax Superstabilizer Total Knee System · Howmedica Corp. · 1991 · recalled0
  1. Root · 1 generation backK904208 Kinemax Superstabilizer Total Knee SystemHowmedica Corp. · 1991 · Recalled
  2. This deviceK963242 Duracon Posterior Femoral SpacerHowmedica Corp. · 1996
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K904208Kinemax Superstabilizer Total Knee SystemHowmedica Corp.19911
0 (this device)K963242Duracon Posterior Femoral SpacerHowmedica Corp.1996—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
FIG. 1 — Lineage of K963242, 1991–1996Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JWH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JWH device

  1. #1 K221479 Persona Personalized Knee Systemscore 22.4 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K915512Duracon Total Knee System Tibial Components
Summary page 1
…Spacer is substantially equivalent to several other legally marketed devices. Examples of these are listed below: 1. Duracon® Total Knee System Distal Femoral Spacers (K915512) - Howmedica 2. Duracon® Total Knee System Distal-Posterior Femoral Spacers (K915512) - Howmedica 3. Kinemax® Plus Superstabilize…
Pfizer Hospital Products Group, Inc.19924
*K904208Kinemax Superstabilizer Total Knee System
Summary page 1
…medica 2. Duracon® Total Knee System Distal-Posterior Femoral Spacers (K915512) - Howmedica 3. Kinemax® Plus Superstabilizer Total Knee System Femoral Posterior Spacers (K904208) - Howmedica 4. Series 7000 Total Knee System Femoral Posterior Spacers - Osteonics Corporation 5. Genesis Total Knee System Fe…
Howmedica Corp.19911
*—Series 7000 Total Knee System Femoral Posterior Spacers
Named without a submission number
—
*—Genesis Total Knee System Femoral Posterior Spacers
Named without a submission number
—
*—Coordinate Total Knee System Femoral Posterior Spacers
Named without a submission number
—
†K910235Pca MTK II Total Knee SystemHowmedica Corp.1991—
†K920034Duracon Modular Femoral Component and Femoral SpacPfizer Hospital Products Group, Inc.19922
†K932070Duracon Stabilizer Femoral Component and InsertHowmedica Corp.1995—
†K954138Duracon Monolithic Stabilizer Femoral ComponentHowmedica Corp.1995—

Also cleared against K915512: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 2 of the 2 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K915512.

How does its category compare?

All JWH devices

JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JWH

20in 2025

2007: 182008: 172009: 112010: 192011: 252012: 332013: 312014: 332015: 272016: 182017: 252018: 252019: 282020: 222021: 242022: 172023: 202024: 192025: 202026 (partial year): 12
2007high 33 (2012) · low 11 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JWH

55in 2025

2007: 74 days median2008: 81 days median2009: 168 days median2010: 85 days median2011: 87 days median2012: 85 days median2013: 128 days median2014: 98 days median2015: 87 days median2016: 88 days median2017: 118 days median2018: 90 days median2019: 133 days median2020: 59 days median2021: 61 days median2022: 56 days median2023: 57 days median2024: 89 days median2025: 55 days median2026 (partial year): 63 days median
2007high 168 (2009) · low 55 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JWH

2in 2025

2007: 142008: 102009: 1092010: 322011: 272012: 852013: 312014: 132015: 112016: 172017: 612018: 142019: 52020: 22021: 82022: 122023: 672024: 72025: 22026 (partial year): 4
2007high 109 (2009) · low 2 (2020)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JWH

9,306in 2025

2007: 1,3052008: 1,4832009: 1,8702010: 3,2862011: 5,1332012: 5,2032013: 6,1352014: 6,7222015: 6,8812016: 7,5862017: 12,2632018: 14,0712019: 14,9872020: 12,5922021: 9,4082022: 8,3642023: 8,9472024: 10,8282025: 9,306
2007high 14,987 (2019) · low 1,305 (2007)2025

MAUDE reports naming product code JWH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071874141,305
20081781101,483
2009111681091,870
20101985323,286
20112587275,133
20123385855,203
201331128316,135
20143398136,722
20152787116,881
20161888177,586
2017251186112,263
201825901414,071
201928133514,987
20202259212,592
2021246189,408
20221756128,364
20232057678,947
20241989710,828
2025205529,306
202612634—

What is it indicated for?

The Duracon® Femoral Posterior Spacer is intended to be used with the femoral components of the Duracon® Total Knee System (reference premarket notifications K910235, K920034, K932070, and K954138) to augment bone loss in the area of the posterior condyle of the femur. Posterior bone loss that requires augmentation by spacers may be noted in primary or revision total knee arthroplasty cases.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K963242: Duracon Posterior Femoral Spacer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K963242

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026